3 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow resiniferatoxin: new trials by email Literature Review of resiniferatoxin trials Research Report on resiniferatoxin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain Resiniferatoxin - Intractable Pain, Palliative Care | Phase 1 / Phase 2 | Not yet recruiting | National Institute of Neurological Disorders and Stroke (NINDS) | 30 | 2026-11-27 | 2026-10-26 |
| Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) Allogeneic NK cells, Rituximab, Tafasitamab - Non Hodgkin Lymphoma, B-cell Non Hodgkin Lymphoma | Phase 1 | Recruiting | Paolo Caimi, MD | 15 | 2026-09-01 | 2026-09-09 |
| Resiniferatoxin for the Management of Refractory Morton s Neuroma Pain Resiniferatoxin - Morton's Neuroma | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 3 | 2025-03-13 | 2026-04-13 |
| Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis Resiniferatoxin, Saline - Osteoarthritis, Knee, Pain, Knee | Phase 1 | Completed | Sorrento Therapeutics, Inc. | 94 | 2018-07-12 | 2021-04-01 |
| Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain Resiniferatoxin - Intractable Cancer Pain | Phase 1 | Completed | Sorrento Therapeutics, Inc. | 17 | 2017-09-01 | 2020-10-20 |
Cancer Pain (2) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Morton Neuroma (1) · Osteoarthritis, Knee (1) · Pain (1) · Pain, Intractable (1)
Sorrento Therapeutics, Inc. (2) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · National Institutes of Health Clinical Center (CC) (1) · Paolo Caimi, MD (1)
United States (5)
Monica Luchi, MD (2) · Andrew J Mannes, M.D. (1) · John D Heiss, M.D. (1) · Paolo Caimi, MD (1)